山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2009年
25期
4-6
,共3页
寡核苷酸,反义%生存素%胃癌肿瘤%细胞凋亡
寡覈苷痠,反義%生存素%胃癌腫瘤%細胞凋亡
과핵감산,반의%생존소%위암종류%세포조망
oligonucleotide,antisense%Survivin%stomach neoplasms%apoptosis
目的 探讨生存素(Survivin)反义寡核苷酸(ASODN)诱导人胃癌细胞SGC7901凋亡的作用.方法 设计合成特异性靶向Survivin的ASODN,将胃癌细胞株分为空白对照组(Sham组)、脂质体转染对照组(Lip组)、正义链转染对照组(Lip-SODN组)和ASODN转染组(Lip-ASODN组).作用48 h后,Western blot法检测各组Survivin表达情况,流式细胞仪检测各组细胞凋亡率,免疫组化SP法检测细胞中PCNA表达情况.结果 脂质体介导Survivin ASODN转染后的胃癌细胞Survivin蛋白表达明显下降;ASODN转染组细胞凋亡率明显高于各对照组(P均<0.05),各对照组间无统计学差异(P>0.05).ASODN转染后胃癌细胞中PCNA表达水平明显降低.结论 Survivin ASODN转染胃癌细胞能下调Survivin蛋白表达,诱导胃癌细胞凋亡,抑制细胞增殖,具有明显的抗癌作用.
目的 探討生存素(Survivin)反義寡覈苷痠(ASODN)誘導人胃癌細胞SGC7901凋亡的作用.方法 設計閤成特異性靶嚮Survivin的ASODN,將胃癌細胞株分為空白對照組(Sham組)、脂質體轉染對照組(Lip組)、正義鏈轉染對照組(Lip-SODN組)和ASODN轉染組(Lip-ASODN組).作用48 h後,Western blot法檢測各組Survivin錶達情況,流式細胞儀檢測各組細胞凋亡率,免疫組化SP法檢測細胞中PCNA錶達情況.結果 脂質體介導Survivin ASODN轉染後的胃癌細胞Survivin蛋白錶達明顯下降;ASODN轉染組細胞凋亡率明顯高于各對照組(P均<0.05),各對照組間無統計學差異(P>0.05).ASODN轉染後胃癌細胞中PCNA錶達水平明顯降低.結論 Survivin ASODN轉染胃癌細胞能下調Survivin蛋白錶達,誘導胃癌細胞凋亡,抑製細胞增殖,具有明顯的抗癌作用.
목적 탐토생존소(Survivin)반의과핵감산(ASODN)유도인위암세포SGC7901조망적작용.방법 설계합성특이성파향Survivin적ASODN,장위암세포주분위공백대조조(Sham조)、지질체전염대조조(Lip조)、정의련전염대조조(Lip-SODN조)화ASODN전염조(Lip-ASODN조).작용48 h후,Western blot법검측각조Survivin표체정황,류식세포의검측각조세포조망솔,면역조화SP법검측세포중PCNA표체정황.결과 지질체개도Survivin ASODN전염후적위암세포Survivin단백표체명현하강;ASODN전염조세포조망솔명현고우각대조조(P균<0.05),각대조조간무통계학차이(P>0.05).ASODN전염후위암세포중PCNA표체수평명현강저.결론 Survivin ASODN전염위암세포능하조Survivin단백표체,유도위암세포조망,억제세포증식,구유명현적항암작용.
Objective To investigate the apoptosis effects of Survivin antisense oligonucleotide (ASODN)on human gastric carcinoma cell SGC7901. Methods ASODN targeting Surviving was designed and constructed. Cultured cells were divided into control group, lipofectin group, oligonucleotide(ODN) group and ASODN group. After transfection for 48 h, Survivin protein expression was detected by Western blot; apoptotic rate (AR) was examined by flow cytometry; the expression of PCNA was detected in gastric cancer cells by immunohistochemical staining. Results The expression of Survivin in SGC7901 cells decreased after transfected with Survivin ASODN. The AR of ASODN group was significantly higher than that of other groups; Immunohistochemical test indicated that transfected ASODN downregulated the expression levels of PCNA. Conclusions Expression of Survivin may decrease in gastric cancer cells after ASODN transfection. ASODN targeting Survivin can induce cell apoptosis, inhibit cell proliferation. Survivin ASODN is a prospective anti-cancer drug